These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4169450)

  • 1. [Use of "Ubretid" in the field of urology].
    Inada T; Ebisuta K; Harada T
    Hinyokika Kiyo; 1967 May; 13(5):429-32. PubMed ID: 4169450
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical appraisal of Ubretid: a new cholinesterase inhibitor].
    Niijima T; Asano M
    Hinyokika Kiyo; 1967 May; 13(5):423-8. PubMed ID: 5624432
    [No Abstract]   [Full Text] [Related]  

  • 3. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenoxybenzamine for symptoms of bladder neck obstruction.
    Drug Ther Bull; 1983 Feb; 21(4):15-6. PubMed ID: 6187524
    [No Abstract]   [Full Text] [Related]  

  • 5. A further report on the effect of distigmine bromide (Ubretid) on the neurogenic bladder.
    Yeo J; Southwell P; Rutowski S; Marchant-Williams H
    Med J Aust; 1974 Aug; 2(6):201-3. PubMed ID: 4424051
    [No Abstract]   [Full Text] [Related]  

  • 6. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contribution to the treatment of irritative manifestations of the bladder].
    Rusch G
    Praxis; 1967 Aug; 56(34):1167-70. PubMed ID: 4174716
    [No Abstract]   [Full Text] [Related]  

  • 8. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
    [No Abstract]   [Full Text] [Related]  

  • 9. [New ways of conservative treatment of bladder neck diseases].
    Massier J
    Wien Klin Wochenschr; 1971 May; 83(19):337-8. PubMed ID: 4104107
    [No Abstract]   [Full Text] [Related]  

  • 10. Male lower urinary tract symptoms and sildenafil.
    Jackson G
    Int J Clin Pract; 2007 Nov; 61(11):1779. PubMed ID: 17935539
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of dysuria with anticholinesterases: Ubretid].
    Oka N; Hasegawa S
    Hinyokika Kiyo; 1967 Jan; 13(1):42-51. PubMed ID: 4169371
    [No Abstract]   [Full Text] [Related]  

  • 12. Defining the role of overactive bladder treatments in men with lower urinary tract symptoms.
    Lemack GE
    Nat Clin Pract Urol; 2007 Apr; 4(4):174-5. PubMed ID: 17415351
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effectiveness of beta-sitosterol in treatment of benign prostatic hyperplasia].
    Senge T; Windeler J; Berges RR; Trampisch HJ
    Urologe A; 1995 Mar; 34(2):130-1. PubMed ID: 7538710
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical management of lower urinary tract symptoms with combined medical therapy.
    Roehrborn CG
    BJU Int; 2008 Nov; 102 Suppl 2():13-7. PubMed ID: 19032605
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urological diseases and salivary gland hormone. (1). Prostatic hypertrophy. (2). Functional failure of the bladder].
    Furusawa T; Azuma T; Mishina T; Murakami T
    Horumon To Rinsho; 1966 Nov; 14(11):915-7. PubMed ID: 4167004
    [No Abstract]   [Full Text] [Related]  

  • 16. [New in Austria approved specialty drugs and new knowledge regarding currently available specialty drugs. Uroflo].
    Wien Klin Wochenschr; 1995; 107(15):472-6. PubMed ID: 7545857
    [No Abstract]   [Full Text] [Related]  

  • 17. [Two drugs have a better outcome. Finasteride plus alpha blocker improves urine flow].
    MMW Fortschr Med; 2003 Nov; 145(47):62. PubMed ID: 14725041
    [No Abstract]   [Full Text] [Related]  

  • 18. Getting ready for certification: urinary tract inflammation and disease.
    Linn MM
    Urol Nurs; 2007 Aug; 27(4):324-5. PubMed ID: 17877104
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacotherapy of functional disorders of the lower urinary tract in the female. 2: Drug therapy of stress incontinence, bladder muscle weakness and increased bladder outflow resistance].
    Schumacher T; Peters FD
    Fortschr Med; 1984 Sep; 102(36):906-8. PubMed ID: 6489903
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of irritable bladder with Ubretid].
    Mishina T
    Hinyokika Kiyo; 1970 Mar; 16(3):134-7. PubMed ID: 5462623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.